81 online
 
Most Popular Choices
Share on Facebook 63 Printer Friendly Page More Sharing
OpEdNews Op Eds   

The Battle for Pandemic Sanity: Hydroxychloroquine Efficacy vs. Its Suppression

By Mike Zimmer  Posted by Mike Zimmer (about the submitter)       (Page 6 of 8 pages) Become a premium member to see this article and all articles as one long page.   21 comments, In Series: Covid-19
Message Mike Zimmer

It seems fitting to conclude on a positive note with these practical, responsible words from Yale epidemiologist Dr. Harvey Risch - words that could well be remembered each day by Dr. Tony Fauci; by the CDC and the FDA; and by any media interested in the public health:

"It is our obligation not to stand by, just 'carefully watching,' as the old and infirm and inner city of us are killed by this disease and our economy is destroyed by it and we have nothing to offer except high-mortality hospital treatment. We have a solution, imperfect, to attempt to deal with the disease. We have to let physicians employing good clinical judgement use it and informed patients choose it. There is a small chance that it may not work. But the urgency demands that we at least start to take that risk and evaluate what happens, and if our situation does not improve we can stop it, but we will know that we did everything that we could instead of sitting by and letting hundreds of thousands die because we did not have the courage to act according to our rational calculations."[xxviii]

*

Note to readers: please click the share buttons above or below. Forward this article to your email lists. Cross post on your blog site, internet forums. etc.

Notes

[i] "SECOND OPINION: Doctors Discuss the Politicization of Hydroxychloroquine," June 18, 2020, at 10:21 min. (https://www.youtube.com/watch?time_continue=7&v=m_JIz780i5w&feature=emb_logo).

[ii] Twitter: https://twitter.com/realDonaldTrump/status/1241367239900778501

[iii] The Lancet, "RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis, by Mandeep R. Mehra et al," Lancet, 5 June 2010 (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31180-6/fulltext).

[iv] Harvey A. Risch, "Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis," Amer. J. Epid, 27 May 2020 (https://academic.oup.com/aje/advance-article/doi/10.1093/aje/kwaa093/5847586). Risch is Professor at the Yale Schools of both Medicine and Public Health.

[v] Elizabeth Woodworth, "The Media Sabotage of Hydroxychloroquine Use for Covid-19: Doctors Worldwide Protest the Disaster," Global Research, 30 June 2020 (https://www.globalresearch.ca/media-sabotage-hydroxychloroquine-covid-19-doctors-worldwide-protest-disaster/5717382).

[vi] X. Yao, F. , et al., "In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),"Clin. Infect. Dis.9 March 2020 (online ahead of print:https://pubmed.ncbi.nlm.nih.gov/32150618/).

Liu, et al., "Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro," Cell Discov, 18 March 2020 p. 16 (https://pubmed.ncbi.nlm.nih.gov/32194981/),

Wang, et al., "Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro," Cell Res, 30, 4 February 2020, pp. 269-271 (https://www.nature.com/articles/s41422-020-0282-0).

[vii] The Chinese studies are cited in this article: P. Gautret P, et al., "Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: a pilot observational study," Travel Medicine and Infectious Disease, March-April 2020 (https://www.sciencedirect.com/science/article/pii/S1477893920301319).

Chen, et al., "Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial," MedRxiv, 10 April 2020, awaiting peer review (https://www.medrxiv.org/content/10.1101/2020.03.22.20040758v3).

[viii] P. Gautret, et al., "Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: a pilot observational study," Travel Medicine and Infectious Disease, March-April 2020 (https://www.sciencedirect.com/science/article/pii/S1477893920301319).

Next Page  1  |  2  |  3  |  4  |  5  |  6  |  7  |  8

(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).

Must Read 4   Well Said 4   Supported 2  
Rate It | View Ratings

Mike Zimmer Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Father and husband, free thinker, with a libertarian socialist bent, published writer, essayist, retired information systems consultant, former experimental psychology graduate student, martial arts teacher, writer of tunes, guitar teacher, (more...)
 

Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines

 
Contact EditorContact Editor
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEd News Newsletter
Name
Email
   (Opens new browser window)
 

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

Masks and Motivated Reasoning

Gold Standard for Handling Covid-19

Trusting the experts

Motivated Reasoning

To View Comments or Join the Conversation:

Tell A Friend